MENU
+Compare
HNSBF
Stock ticker: OTC
AS OF
Dec 31 closing price
Price
$3.00
Change
+$0.17 (+6.01%)
Capitalization
241.73M

HNSBF Hansa Medical AB Forecast, Technical & Fundamental Analysis

Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Scheelevagen 22
Phone
+46 46165670
Employees
159
Web
https://www.hansabiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MELSX16.470.12
+0.73%
Morgan Stanley Inst EMkts Ldrs R6
JLFSX12.430.09
+0.73%
JHancock Global Climate Action I
DMIDX28.820.18
+0.63%
BNY Mellon MidCap Index I
ARTIX34.170.10
+0.29%
Artisan International Investor
FCENX13.850.01
+0.07%
Franklin International Core Equity Adv

HNSBF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSBF has been loosely correlated with ENSC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSBF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSBF
1D Price
Change %
HNSBF100%
N/A
ENSC - HNSBF
33%
Loosely correlated
+1.76%
CVAC - HNSBF
33%
Poorly correlated
+0.93%
MLLCF - HNSBF
27%
Poorly correlated
N/A
GNPX - HNSBF
25%
Poorly correlated
-3.59%
GRI - HNSBF
25%
Poorly correlated
-0.69%
More